RGD DISEASE ONTOLOGY - ANNOTATIONS
RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
Term: Transplant Rejection
Accession: DOID:9004283
browse the term
Definition: A process in which a transplant recipient's immune system attacks the transplanted organ or tissue. The rejection can be hyperacute (occurring within a few minutes), acute (occurring within days to months), or chronic (occurring over many years).
G
Acvr2b
activin receptor IIB
treatment
ISO
human construct in rat model
RGD
PMID:27732750
RGD:329322881
NCBI chr 9:119,231,081...119,271,214
Ensembl chr 9:119,231,184...119,264,061
G
Apoa1
apolipoprotein A-I
ISO
protein:decreased expression:plasma
RGD
PMID:21730889
RGD:7241209
NCBI chr 9:46,139,928...46,141,767
Ensembl chr 9:46,139,878...46,141,764
G
Arrb1
arrestin, beta 1
ISO
mRNA:decreased expression:blood, leukocyte
RGD
PMID:21193245
RGD:13506894
NCBI chr 7:99,184,356...99,255,979
Ensembl chr 7:99,184,673...99,255,978
G
Arrb2
arrestin, beta 2
ISO
mRNA, protein:decreased expression:blood, leukocyte, monocyte
RGD
PMID:21193245
RGD:13506894
NCBI chr11:70,323,051...70,331,654
Ensembl chr11:70,323,461...70,331,654
G
Bag6
BCL2-associated athanogene 6
susceptibility
ISO
DNA:haplotype: :rs10484558(human)
RGD
PMID:25111513
RGD:14390152
NCBI chr17:35,354,132...35,366,297
Ensembl chr17:35,354,154...35,366,298
G
Ccl2
C-C motif chemokine ligand 2
susceptibility
ISO IMP
kidney;DNA:snp:promoter:g.-2518A>G (human)
RGD
PMID:12239249 PMID:14662900
RGD:8548879 , RGD:8657367
NCBI chr11:81,926,403...81,928,278
Ensembl chr11:81,926,397...81,928,279
G
Ccl3
C-C motif chemokine ligand 3
ISO
RGD
PMID:20688906
RGD:7241797
NCBI chr11:83,538,669...83,540,204
Ensembl chr11:83,538,670...83,540,181
G
Ccr2
C-C motif chemokine receptor 2
IMP
RGD
PMID:14662900
RGD:8657367
NCBI chr 9:123,901,954...123,913,594
Ensembl chr 9:123,901,987...123,913,594
G
Ccr5
C-C motif chemokine receptor 5
treatment
ISO
RGD
PMID:23498802 PMID:23446583
RGD:8552228 , RGD:8552231
NCBI chr 9:123,921,557...123,934,153
Ensembl chr 9:123,921,580...123,947,736
G
Cd274
CD274 antigen
IMP
RGD
PMID:14662900
RGD:8657367
NCBI chr19:29,339,428...29,365,495
Ensembl chr19:29,344,855...29,365,495
G
Cd4
CD4 antigen
treatment
ISO IMP
RGD
PMID:1704648 PMID:11081762
RGD:10058956 , RGD:10058974
NCBI chr 6:124,841,656...124,865,210
Ensembl chr 6:124,841,655...124,865,184
G
Cd40
CD40 antigen
disease_progression treatment
ISO
associated with Diabetes Mellitus, Experimental
RGD
PMID:15221125 PMID:14698004 PMID:21472009
RGD:7248441 , RGD:8547788 , RGD:7248755
NCBI chr 2:164,897,535...164,913,574
Ensembl chr 2:164,897,547...164,914,868
G
Cd40lg
CD40 ligand
treatment
ISO IMP
protein:increased expression:blood, T cell associated with Diabetes Mellitus
RGD
PMID:22948742 PMID:15808676 PMID:10949194 PMID:15016184
RGD:7248420 , RGD:8547783 , RGD:7248719 , RGD:7248598
NCBI chr X:56,257,448...56,269,402
Ensembl chr X:56,257,503...56,269,402
G
Chrna3
cholinergic receptor, nicotinic, alpha polypeptide 3
ISO
RGD
PMID:25121092
RGD:151347544
NCBI chr 9:54,917,401...54,933,846
Ensembl chr 9:54,917,395...54,933,846
G
Chrnb4
cholinergic receptor, nicotinic, beta polypeptide 4
ISO
RGD
PMID:25121092
RGD:151347544
NCBI chr 9:54,935,438...54,956,236
Ensembl chr 9:54,935,438...54,956,063
G
Col1a2
collagen, type I, alpha 2
ISO
mRNA:increased expression:kidney
RGD
PMID:20150539
RGD:7248773
NCBI chr 6:4,505,618...4,541,543
Ensembl chr 6:4,504,814...4,541,544
G
Col3a1
collagen, type III, alpha 1
ISO
mRNA:increased expression:kidney
RGD
PMID:20150539
RGD:7248773
NCBI chr 1:45,350,698...45,388,866
Ensembl chr 1:45,350,698...45,388,866
G
Csf1
colony stimulating factor 1 (macrophage)
ISO
mRNA:increased expression:kidney
RGD
PMID:19196448 PMID:11981428
RGD:7257570 , RGD:7257590
NCBI chr 3:107,648,364...107,668,048
Ensembl chr 3:107,648,364...107,667,785
G
Csf1r
colony stimulating factor 1 receptor
ISO
RGD
PMID:24056626
RGD:151665812
NCBI chr18:61,238,644...61,264,211
Ensembl chr18:61,233,670...61,265,221
G
Csf3
colony stimulating factor 3 (granulocyte)
treatment
ISO
RGD
PMID:18589159
RGD:11039422
NCBI chr11:98,591,287...98,594,457
Ensembl chr11:98,592,089...98,594,455
G
Ctla4
cytotoxic T-lymphocyte-associated protein 4
susceptibility
IMP ISO
DNA:SNP: :rs231775, korean(human) DNA:SNP: :rs733618, chinese(human)
RGD
PMID:12096784 PMID:20940051 PMID:22418270 PMID:18074399 PMID:14551031
RGD:7204515 , RGD:7204678 , RGD:7204671 , RGD:7204518 , RGD:7204516
NCBI chr 1:60,948,184...60,954,991
Ensembl chr 1:60,926,159...60,954,991
G
Cxcl10
C-X-C motif chemokine ligand 10
severity
ISO
RGD
PMID:28245475
RGD:27095950
NCBI chr 5:92,494,497...92,496,748
Ensembl chr 5:92,494,497...92,496,748
G
Cxcr1
C-X-C motif chemokine receptor 1
ISO
DNA:SNP:promoter:g.-2668G>A (rs2671222) (human)
RGD
PMID:21452410
RGD:7257676
NCBI chr 1:74,228,862...74,233,867
Ensembl chr 1:74,230,944...74,233,790
G
Cxcr2
C-X-C motif chemokine receptor 2
ISO
RGD
PMID:15840022 PMID:22882432
RGD:7257683 , RGD:7257690
NCBI chr 1:74,193,153...74,200,405
Ensembl chr 1:74,193,150...74,200,405
G
Dhodh
dihydroorotate dehydrogenase
treatment
ISO
RGD
PMID:8443191
RGD:11040447
NCBI chr 8:110,319,876...110,335,330
Ensembl chr 8:110,317,975...110,335,305
G
Ece1
endothelin converting enzyme 1
ISO
RGD
PMID:10401760
RGD:7244165
NCBI chr 4:137,589,548...137,692,540
Ensembl chr 4:137,589,548...137,692,540
G
Entpd1
ectonucleoside triphosphate diphosphohydrolase 1
IMP
RGD
PMID:10656876
RGD:9685445
NCBI chr19:40,600,810...40,730,046
Ensembl chr19:40,600,810...40,730,046
G
Ern1
endoplasmic reticulum to nucleus signalling 1
treatment
ISO
RGD
PMID:31828147
RGD:35316072
NCBI chr11:106,285,474...106,378,701
Ensembl chr11:106,285,476...106,378,678
G
Ezh2
enhancer of zeste 2 polycomb repressive complex 2 subunit
treatment
ISO
RGD
PMID:27784285
RGD:126781722
NCBI chr 6:47,507,208...47,613,843
Ensembl chr 6:47,507,073...47,572,275
G
Fasl
Fas ligand
ISO
mRNA, protein:increased expression:liver
RGD
PMID:10357921
RGD:14700698
NCBI chr 1:161,608,260...161,616,064
Ensembl chr 1:161,608,258...161,616,064
G
Fcgr3
Fc receptor, IgG, low affinity III
treatment
ISO
RGD
PMID:10762218
RGD:9588604
NCBI chr 1:170,878,738...170,893,477
Ensembl chr 1:170,878,743...170,892,504
G
Foxp3
forkhead box P3
treatment
ISO IEP
mRNA:increased expression:liver
RGD
PMID:17414718 PMID:21199671 PMID:28457422
RGD:38456005 , RGD:38599144 , RGD:38549577
NCBI chr X:7,445,915...7,461,482
Ensembl chr X:7,439,883...7,461,484
G
Gfer
growth factor, augmenter of liver regeneration
ISO
RGD
PMID:22819311
RGD:9685732
NCBI chr17:24,912,164...24,915,065
Ensembl chr17:24,912,161...24,915,130
G
Got2
glutamatic-oxaloacetic transaminase 2, mitochondrial
treatment
ISO
RGD
PMID:28596681
RGD:13504864
NCBI chr 8:96,590,761...96,615,029
Ensembl chr 8:96,590,762...96,615,175
G
Gstt1
glutathione S-transferase, theta 1
ISO
associated with Hemoglobinopathies;DNA:deletion:: (human)
RGD
PMID:20348973
RGD:10450792
NCBI chr10:75,619,647...75,634,418
Ensembl chr10:75,619,647...75,634,418
G
H2-Ab1
histocompatibility 2, class II antigen A, beta 1
ISO
RGD
PMID:1547813
RGD:7421554
NCBI chr17:34,482,201...34,488,392
Ensembl chr17:34,476,663...34,488,393
G
H2-M2
histocompatibility 2, M region locus 2
treatment
ISO
human peptide in rat model; HLA-B7
RGD
PMID:9233694
RGD:7387273
NCBI chr17:37,791,742...37,794,445
Ensembl chr17:37,791,742...37,794,443
G
H2-Q4
histocompatibility 2, Q region locus 4
treatment
ISO
human peptide in rat model; HLA-B7
RGD
PMID:9233694
RGD:7387273
NCBI chr17:35,598,593...35,603,650
Ensembl chr17:35,598,593...35,604,266
G
Havcr1
hepatitis A virus cellular receptor 1
ISO
RGD
PMID:23435265
RGD:7244382
NCBI chr11:46,630,644...46,670,405
Ensembl chr11:46,625,907...46,670,405
G
Havcr2
hepatitis A virus cellular receptor 2
ISO
mRNA:increased expression:Leukocytes, Mononuclear: mRNA,protein:increased expression:lung:
RGD
PMID:22172823 PMID:24508263
RGD:7245954 , RGD:9686116
NCBI chr11:46,345,758...46,372,082
Ensembl chr11:46,345,762...46,372,082
G
Hspd1
heat shock protein 1 (chaperonin)
ISO
RGD
PMID:23953577
RGD:12910541
NCBI chr 1:55,116,992...55,127,402
Ensembl chr 1:55,116,994...55,127,402
G
Ifng
interferon gamma
IDA
RGD
PMID:22564629
RGD:7364833
NCBI chr10:118,276,951...118,281,799
Ensembl chr10:118,276,951...118,281,797
G
Ikbkb
inhibitor of kappaB kinase beta
treatment
ISO
mRNA:increased expression:kidney
RGD
PMID:19249479 PMID:20500684
RGD:7495769 , RGD:4892204
NCBI chr 8:23,149,228...23,196,605
Ensembl chr 8:23,149,228...23,196,605
G
Il10
interleukin 10
treatment
IDA ISO
RGD
PMID:22564629 PMID:17275523 PMID:23870834
RGD:7364833 , RGD:11049523 , RGD:7364994
NCBI chr 1:130,947,459...130,952,707
Ensembl chr 1:130,947,582...130,952,711
G
Il13
interleukin 13
treatment
ISO
mRNA:increased expression:liver
RGD
PMID:17902182 PMID:17532783 PMID:17331844
RGD:8549629 , RGD:10402939 , RGD:8549647
NCBI chr11:53,522,150...53,525,529
Ensembl chr11:53,522,151...53,525,529
G
Il15
interleukin 15
ISO
mRNA:increased expression:liver
RGD
PMID:17532783
RGD:10402939
NCBI chr 8:83,058,253...83,129,883
Ensembl chr 8:83,058,261...83,129,851
G
Il17a
interleukin 17A
treatment
IMP ISO
protein:increased expression:liver, serum (rat)
RGD
PMID:20651239 PMID:23429965 PMID:21043049
RGD:9068426 , RGD:9068938 , RGD:4781440
NCBI chr 1:20,801,129...20,804,720
Ensembl chr 1:20,801,129...20,804,720
G
Il18
interleukin 18
ISO
RGD
PMID:21962809
RGD:8655943
NCBI chr 9:50,466,000...50,493,141
Ensembl chr 9:50,466,127...50,493,140
G
Il18bp
interleukin 18 binding protein
ISO
RGD
PMID:21962809
RGD:8655943
NCBI chr 7:101,664,281...101,669,699
Ensembl chr 7:101,664,092...101,667,897
G
Il1b
interleukin 1 beta
severity
ISO
DNA:snp:intron:g.3962C>T (human)
RGD
PMID:22663993 PMID:8094579
RGD:7175098 , RGD:7401188
NCBI chr 2:129,206,490...129,213,059
Ensembl chr 2:129,206,490...129,213,059
G
Il1rn
interleukin 1 receptor antagonist
treatment
ISO
cornea transplant; human protein in a mouse model
RGD
PMID:9175817
RGD:8549799
NCBI chr 2:24,226,872...24,241,503
Ensembl chr 2:24,226,865...24,241,506
G
Il2
interleukin 2
treatment
IDA IMP ISO
RGD
PMID:22564629 PMID:18089405 PMID:3291556
RGD:7364833 , RGD:10047078 , RGD:8662936
NCBI chr 3:37,174,862...37,180,103
Ensembl chr 3:37,174,672...37,180,108
G
Il21
interleukin 21
ISO
associated with hepatitis B;DNA:SNPs, haplotype:intron, CDS:1472G>T, 5250C>T (rs2055979, rs4833837) (human)
RGD
PMID:23656167
RGD:127285550
NCBI chr 3:37,276,908...37,286,785
Ensembl chr 3:37,276,908...37,286,785
G
Il2rb
interleukin 2 receptor, beta chain
ameliorates
IMP
RGD
PMID:9293878
RGD:42733040
NCBI chr15:78,363,456...78,396,569
Ensembl chr15:78,363,456...78,379,471
G
Il5
interleukin 5
treatment
ISO
RGD
PMID:11267027
RGD:11354977
NCBI chr11:53,611,621...53,615,930
Ensembl chr11:53,611,621...53,615,933
G
Il7
interleukin 7
ISO
mRNA:increased expression:liver
RGD
PMID:17532783
RGD:10402939
NCBI chr 3:7,637,088...7,678,820
Ensembl chr 3:7,635,054...7,678,820
G
Itga4
integrin alpha 4
treatment
IMP
RGD
PMID:9721793
RGD:9698437
NCBI chr 2:79,084,767...79,163,458
Ensembl chr 2:79,085,770...79,163,467
G
Kdr
kinase insert domain protein receptor
IMP
RGD
PMID:22997228
RGD:8549738
NCBI chr 5:76,093,487...76,139,880
Ensembl chr 5:76,093,487...76,139,118
G
Kit
KIT proto-oncogene receptor tyrosine kinase
ISO
mRNA:increased expression:liver:
RGD
PMID:9862859
RGD:12910749
NCBI chr 5:75,735,647...75,817,382
Ensembl chr 5:75,735,576...75,817,382
G
Klrk1
killer cell lectin-like receptor subfamily K, member 1
ISO
RGD
PMID:20306467
RGD:9685184
NCBI chr 6:129,587,286...129,600,863
Ensembl chr 6:129,587,286...129,600,827
G
Lta
lymphotoxin A
treatment
ISO
RGD
PMID:8356596 PMID:2338821
RGD:8548835 , RGD:8548836
NCBI chr17:35,422,141...35,424,568
Ensembl chr17:35,422,141...35,424,327
G
Mmp3
matrix metallopeptidase 3
ISO
RGD
PMID:22845765
RGD:7241226
NCBI chr 9:7,445,845...7,455,975
Ensembl chr 9:7,445,822...7,455,975
G
Muc2
mucin 2
ISO
RGD
PMID:12717211
RGD:7349372
NCBI chr 7:141,276,583...141,308,428
Ensembl chr 7:141,276,583...141,308,430
G
Muc4
mucin 4
ISO
RGD
PMID:12717211
RGD:7349372
NCBI chr16:32,555,089...32,602,786
Ensembl chr16:32,555,015...32,602,754
G
Myc
myelocytomatosis oncogene
ISO
cornea
RGD
PMID:22149555
RGD:7240566
NCBI chr15:61,857,190...61,862,210
Ensembl chr15:61,857,240...61,862,223
G
Nfkbia
nuclear factor of kappa light polypeptide gene enhancer in B cells inhibitor, alpha
treatment
IEP ISO
RGD
PMID:19399405 PMID:31828147
RGD:10413870 , RGD:35316072
NCBI chr12:55,536,194...55,539,432
Ensembl chr12:55,536,195...55,539,432
G
Nos3
nitric oxide synthase 3, endothelial cell
treatment
ISO
RGD
PMID:29218089
RGD:13504718
NCBI chr 5:24,569,772...24,589,472
Ensembl chr 5:24,569,808...24,589,472
G
Nppa
natriuretic peptide type A
treatment
ISO
RGD
PMID:23826817
RGD:7297054
NCBI chr 4:148,085,179...148,086,531
Ensembl chr 4:148,085,179...148,086,536
G
Nr3c1
nuclear receptor subfamily 3, group C, member 1
ISO
protein:decreased activity:blood, mononuclear cell
RGD
PMID:10959477
RGD:7174721
NCBI chr18:39,543,598...39,652,485
Ensembl chr18:39,543,598...39,652,474
G
Pdcd1
programmed cell death 1
severity
ISO IMP
mRNA:increased expression:leukocytes, Mononuclear:
RGD
PMID:21518556 PMID:17198268 PMID:17489865
RGD:7248673 , RGD:9589063 , RGD:9589060
NCBI chr 1:93,966,027...93,980,278
Ensembl chr 1:93,966,027...93,980,278
G
Pdgfd
platelet-derived growth factor, D polypeptide
ISO
RGD
PMID:19213942
RGD:9854642
NCBI chr 9:6,168,377...6,534,284
Ensembl chr 9:6,168,584...6,378,850
G
Pdgfrb
platelet derived growth factor receptor, beta polypeptide
ISO
RGD
PMID:10458478
RGD:1625382
NCBI chr18:61,178,194...61,218,139
Ensembl chr18:61,178,222...61,218,133
G
Pin1
peptidyl-prolyl cis/trans isomerase, NIMA-interacting 1
ISO
RGD
PMID:17311089
RGD:8693431
NCBI chr 9:20,563,335...20,575,008
Ensembl chr 9:20,563,391...20,577,880
G
Plat
plasminogen activator, tissue
susceptibility
ISO
protein:increased expression:plasma (human)
RGD
PMID:11423054
RGD:11541079
NCBI chr 8:23,247,655...23,272,864
Ensembl chr 8:23,247,743...23,272,860
G
Plau
plasminogen activator, urokinase
ISO
mRNA, protein:increased expression:kidney (human)
RGD
PMID:14531820
RGD:7241140
NCBI chr14:20,886,730...20,893,456
Ensembl chr14:20,886,728...20,893,453
G
Prrc2a
proline-rich coiled-coil 2A
susceptibility
ISO
DNA:haplotype: :rs11538264(human)
RGD
PMID:25111513
RGD:14390152
NCBI chr17:35,368,052...35,384,877
Ensembl chr17:35,368,052...35,383,873
G
Psmb9
proteasome (prosome, macropain) subunit, beta type 9 (large multifunctional peptidase 2)
severity
ISO
protein:increased expression:liver, kidney (rat)
RGD
PMID:22834313
RGD:9854627
NCBI chr17:34,401,006...34,406,347
Ensembl chr17:34,400,961...34,406,738
G
Rapgef3
Rap guanine nucleotide exchange factor (GEF) 3
treatment
ISO
RGD
PMID:18178058
RGD:9835362
NCBI chr15:97,637,886...97,666,300
Ensembl chr15:97,642,651...97,665,853
G
Rela
v-rel reticuloendotheliosis viral oncogene homolog A (avian)
treatment
ISO
RGD
PMID:31828147
RGD:35316072
NCBI chr19:5,686,993...5,698,162
Ensembl chr19:5,687,511...5,698,158
G
Relb
avian reticuloendotheliosis viral (v-rel) oncogene related B
treatment
ISO
RGD
PMID:23196258
RGD:7777161
NCBI chr 7:19,340,142...19,363,352
Ensembl chr 7:19,340,142...19,363,363
G
Sell
selectin, lymphocyte
ISO
RGD
PMID:11095659
RGD:7175511
NCBI chr 1:163,889,556...163,908,354
Ensembl chr 1:163,889,551...163,911,750
G
Slc5a7
solute carrier family 5 (choline transporter), member 7
ISO
protein:increased expression:kidney, mononuclear cell
RGD
PMID:19201987
RGD:9999387
NCBI chr17:54,580,618...54,606,071
Ensembl chr17:54,580,618...54,606,062
G
Spi1
Spi-1 proto-oncogene
treatment
ISO
RGD
PMID:24282365
RGD:9586451
NCBI chr 2:90,912,750...90,946,104
Ensembl chr 2:90,912,735...90,946,101
G
Stat4
signal transducer and activator of transcription 4
ISO
DNA:SNP: :rs7574865 (human)
RGD
PMID:21237270
RGD:7207871
NCBI chr 1:52,026,265...52,146,348
Ensembl chr 1:52,026,307...52,146,348
G
Tbxa2r
thromboxane A2 receptor
ISO
RGD
PMID:7964472
RGD:11059606
NCBI chr10:81,164,102...81,171,008
Ensembl chr10:81,164,565...81,171,006
G
Tlr2
toll-like receptor 2
IMP ISO
liver;DNA:SNP: :p.R753Q (human) kidney
RGD
PMID:22042224 PMID:20038715 PMID:20090572 PMID:20628182 PMID:20628182
RGD:7207901 , RGD:7240555 , RGD:7240554 , RGD:7240551 , RGD:7240551
NCBI chr 3:83,743,579...83,749,045
Ensembl chr 3:83,743,579...83,749,074
G
Tlr4
toll-like receptor 4
IMP
pancreatic islet
RGD
PMID:20642685 PMID:20038715
RGD:7240548 , RGD:7240555
NCBI chr 4:66,745,788...66,765,338
Ensembl chr 4:66,745,821...66,848,521
G
Tlr9
toll-like receptor 9
susceptibility
ISO
kidney; DNA:snp:exon:g.+2848G>A rs352140 (human, North Indian)
RGD
PMID:22251233
RGD:7246885
NCBI chr 9:106,099,797...106,104,075
Ensembl chr 9:106,099,797...106,104,082
G
Tnf
tumor necrosis factor
treatment
ISO
protein:increased expression:heart,serum:
RGD
PMID:2038191 PMID:2338821 PMID:8094579
RGD:7394793 , RGD:8548836 , RGD:7401188
NCBI chr17:35,418,343...35,420,983
Ensembl chr17:35,418,357...35,420,983
G
Tnfrsf1b
tumor necrosis factor receptor superfamily, member 1b
ISO
RGD
PMID:19298452
RGD:7245520
NCBI chr 4:144,938,938...144,973,453
Ensembl chr 4:144,940,033...144,973,440
G
Tpmt
thiopurine methyltransferase
ISO
RGD
PMID:24121523
RGD:11038722
NCBI chr13:47,175,463...47,196,833
Ensembl chr13:47,175,958...47,198,213
G
Tpo
thyroid peroxidase
ISO
RGD
PMID:19506389
RGD:7207487
NCBI chr12:30,104,658...30,182,983
Ensembl chr12:30,104,658...30,182,623
G
Traf2
TNF receptor-associated factor 2
treatment
ISO
RGD
PMID:31828147
RGD:35316072
NCBI chr 2:25,407,994...25,436,952
Ensembl chr 2:25,407,994...25,436,952
G
Xdh
xanthine dehydrogenase
treatment
ISO
RGD
PMID:24768926
RGD:13209011
NCBI chr17:74,190,890...74,257,191
Ensembl chr17:74,190,890...74,257,191
G
F3
coagulation factor III
ISO
RGD
PMID:9916935
RGD:11341701
NCBI chr 3:121,517,186...121,528,701
Ensembl chr 3:121,517,186...121,528,697
G
Hnrnpk
heterogeneous nuclear ribonucleoprotein K
ISO
RGD
PMID:21489814
RGD:155260371
NCBI chr13:58,538,946...58,551,157
Ensembl chr13:58,538,956...58,551,157
G
Pdgfd
platelet-derived growth factor, D polypeptide
ISO
RGD
PMID:19213942
RGD:9854642
NCBI chr 9:6,168,377...6,534,284
Ensembl chr 9:6,168,584...6,378,850
G
Ager
advanced glycosylation end product-specific receptor
treatment
ISO
RGD
PMID:22217518 PMID:23769041
RGD:7245568 , RGD:8695995
NCBI chr17:34,816,545...34,819,911
Ensembl chr17:34,816,836...34,819,910
G
C3
complement component 3
treatment
ISO
RGD
PMID:25122638
RGD:11040803
NCBI chr17:57,510,967...57,535,136
Ensembl chr17:57,510,970...57,535,136
G
Cd40
CD40 antigen
treatment
ISO
RGD
PMID:22826618
RGD:11352297
NCBI chr 2:164,897,535...164,913,574
Ensembl chr 2:164,897,547...164,914,868
G
Cd40lg
CD40 ligand
treatment
ISO
liver
RGD
PMID:22826618
RGD:11352297
NCBI chr X:56,257,448...56,269,402
Ensembl chr X:56,257,503...56,269,402
G
F7
coagulation factor VII
treatment
ISO
human protein in a rat model
RGD
PMID:12095034
RGD:11049508
NCBI chr 8:13,075,499...13,085,809
Ensembl chr 8:13,076,034...13,085,809
G
Hmgb1
high mobility group box 1
treatment
ISO
RGD
PMID:22217518
RGD:7245568
NCBI chr 5:148,983,512...148,989,867
Ensembl chr 5:148,983,512...149,121,299
G
Kcnn4
potassium intermediate/small conductance calcium-activated channel, subfamily N, member 4
ameliorates
ISO
RGD
PMID:24312257
RGD:401700379
NCBI chr 7:24,069,750...24,084,635
Ensembl chr 7:24,069,688...24,086,115
G
Mtor
mechanistic target of rapamycin kinase
treatment
ISO
RGD
PMID:23985719
RGD:10041002
NCBI chr 4:148,533,039...148,642,142
Ensembl chr 4:148,533,068...148,642,140
G
Tnf
tumor necrosis factor
treatment
ISO
RGD
PMID:24598936
RGD:10450586
NCBI chr17:35,418,343...35,420,983
Ensembl chr17:35,418,357...35,420,983
G
Aco1
aconitase 1
ISO
RGD
PMID:20176611
RGD:11541086
NCBI chr 4:40,143,429...40,199,011
Ensembl chr 4:40,143,081...40,198,338
G
Alb
albumin
disease_progression
ISO
RGD
PMID:24370342
RGD:11035281
NCBI chr 5:90,608,729...90,624,461
Ensembl chr 5:90,608,756...90,624,461
G
Ccl3
C-C motif chemokine ligand 3
ISO
RGD
PMID:17298994
RGD:7241819
NCBI chr11:83,538,669...83,540,204
Ensembl chr11:83,538,670...83,540,181
G
Ccn2
cellular communication network factor 2
disease_progression
ISO
mRNA, protein:increased expression:kidney (rat)
RGD
PMID:19921985
RGD:150517553
NCBI chr10:24,471,340...24,474,581
Ensembl chr10:24,471,340...24,474,581
G
Clu
clusterin
treatment
ISO
RGD
PMID:22494435
RGD:9068431
NCBI chr14:66,206,093...66,218,992
Ensembl chr14:66,205,932...66,218,996
G
Cs
citrate synthase
treatment
ISO
RGD
PMID:20005400
RGD:243048470
NCBI chr10:128,173,596...128,198,351
Ensembl chr10:128,173,603...128,198,348
G
Mmp3
matrix metallopeptidase 3
ISO
RGD
PMID:22845765
RGD:7241226
NCBI chr 9:7,445,845...7,455,975
Ensembl chr 9:7,445,822...7,455,975
G
Mmp7
matrix metallopeptidase 7
treatment
ISO
RGD
PMID:18209025
RGD:9685339
NCBI chr 9:7,692,095...7,699,587
Ensembl chr 9:7,692,091...7,699,586
G
Pdgfa
platelet derived growth factor, alpha
ISO
RGD
PMID:11889420
RGD:11080974
NCBI chr 5:138,961,761...138,986,336
Ensembl chr 5:138,961,769...138,983,125
G
Pdgfb
platelet derived growth factor, B polypeptide
ISO
mRNA:increased expression:kidney:
RGD
PMID:15785371 PMID:11889420
RGD:10449491 , RGD:11080974
NCBI chr15:79,880,066...79,899,178
Ensembl chr15:79,880,075...79,899,178
G
Pdgfra
platelet derived growth factor receptor, alpha polypeptide
ISO
RGD
PMID:11889420
RGD:11080974
NCBI chr 5:75,311,988...75,358,867
Ensembl chr 5:75,312,953...75,358,876
G
Pdgfrb
platelet derived growth factor receptor, beta polypeptide
ISO
RGD
PMID:11889420
RGD:11080974
NCBI chr18:61,178,194...61,218,139
Ensembl chr18:61,178,222...61,218,133
G
Plau
plasminogen activator, urokinase
ISO
protein:increased secretion:T lymphocyte (human)
RGD
PMID:16387096
RGD:7241259
NCBI chr14:20,886,730...20,893,456
Ensembl chr14:20,886,728...20,893,453
G
Pparg
peroxisome proliferator activated receptor gamma
ISO
protein:increased expression:kidney:
RGD
PMID:16221712
RGD:13208600
NCBI chr 6:115,337,828...115,467,365
Ensembl chr 6:115,337,912...115,467,360
G
Serpine1
serine (or cysteine) peptidase inhibitor, clade E, member 1
treatment
ISO
protein:increased expression:kidney:
RGD
PMID:16221712 PMID:18192922
RGD:13208600 , RGD:13208601
NCBI chr 5:137,090,358...137,101,126
Ensembl chr 5:137,090,358...137,101,122
G
Epas1
endothelial PAS domain protein 1
ISO
mRNA:increased expression:lung
RGD
PMID:22305384
RGD:10395369
NCBI chr17:87,061,292...87,140,838
Ensembl chr17:87,061,128...87,140,838
G
Cd274
CD274 antigen
treatment
ISO
RGD
PMID:22300371
RGD:41412184
NCBI chr19:29,339,428...29,365,495
Ensembl chr19:29,344,855...29,365,495
G
Cd4
CD4 antigen
treatment
ISO
RGD
PMID:1358194
RGD:10059315
NCBI chr 6:124,841,656...124,865,210
Ensembl chr 6:124,841,655...124,865,184
G
Il1rn
interleukin 1 receptor antagonist
ISO
human gene in a rat model
RGD
PMID:23723965
RGD:9684950
NCBI chr 2:24,226,872...24,241,503
Ensembl chr 2:24,226,865...24,241,506
G
Fto
FTO alpha-ketoglutarate dependent dioxygenase
ISO
DNA:SNP: :rs17817449 (human)
RGD
PMID:30408245
RGD:329845888
NCBI chr 8:92,039,995...92,395,061
Ensembl chr 8:92,040,153...92,395,067
G
Ccn2
cellular communication network factor 2
exacerbates
ISO
protein:increased expression:urine (rat)
RGD
PMID:19921985
RGD:150517553
NCBI chr10:24,471,340...24,474,581
Ensembl chr10:24,471,340...24,474,581
G
Cd40lg
CD40 ligand
treatment
IMP
RGD
PMID:12244161
RGD:7248713
NCBI chr X:56,257,448...56,269,402
Ensembl chr X:56,257,503...56,269,402
G
Gata2
GATA binding protein 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28569748
NCBI chr 6:88,170,873...88,184,014
Ensembl chr 6:88,170,873...88,184,014
G
Gpx3
glutathione peroxidase 3
treatment
ISO
RGD
PMID:29290803
RGD:401827126
NCBI chr11:54,793,680...54,801,213
Ensembl chr11:54,793,279...54,801,203
G
Icam1
intercellular adhesion molecule 1
treatment
ISO
RGD
PMID:22617707 PMID:10666412
RGD:8547722 , RGD:11520779
NCBI chr 9:20,927,236...20,940,110
Ensembl chr 9:20,927,281...20,940,113
G
Il10
interleukin 10
treatment
ISO
RGD
PMID:21911153
RGD:11049478
NCBI chr 1:130,947,459...130,952,707
Ensembl chr 1:130,947,582...130,952,711
G
Npy
neuropeptide Y
ISO
mRNA, protein:decreased expression:blood, mononuclear cell
RGD
PMID:18981110
RGD:10448956
NCBI chr 6:49,799,690...49,806,487
Ensembl chr 6:49,799,690...49,806,487
G
Pf4
platelet factor 4
ameliorates
ISO
RGD
PMID:24986443
RGD:329901907
NCBI chr 5:90,920,362...90,921,242
Ensembl chr 5:90,920,294...90,921,242
G
Selp
selectin, platelet
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28569748
NCBI chr 1:163,942,833...163,977,595
Ensembl chr 1:163,942,833...163,977,595
G
Senp1
SUMO1/sentrin specific peptidase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28569748
NCBI chr15:97,936,625...97,991,625
Ensembl chr15:97,936,625...97,991,625
G
Tnf
tumor necrosis factor
treatment
ISO
liver
RGD
PMID:18972563
RGD:15023490
NCBI chr17:35,418,343...35,420,983
Ensembl chr17:35,418,357...35,420,983
G
Vcam1
vascular cell adhesion molecule 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28569748
NCBI chr 3:115,903,669...115,923,337
Ensembl chr 3:115,903,598...115,923,337
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all